Arabic Arabic English English French French German German

Researchers identify multiple molecules that shut down SARS-Cov-2 polymerase reaction

Researchers have identified a library of molecules that shut down the SARS-CoV-2 polymerase reaction, a key step that establishes the potential of these molecules as lead compounds to be further modified for the development of COVID-19 therapeutics. Five of these molecules are already FDA-approved for use in the treatment of other viral infections including HIV/AIDS, cytomegalovirus, and hepatitis B.
Disclaimer: This story is auto-aggregated by a computer program and has not been created or edited by HFACULTY News. Publisher: Top Health News — ScienceDaily Click this link to read the full content from the Publisher Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

National security determinations

Next Post

Universal gut microbiome-derived signature predicts cirrhosis

Related Posts

Mali: lawyers

The following list has been prepared for the convenience of British Nationals who may require legal advice and…
Read More